Results 241 to 250 of about 69,907 (257)
Some of the next articles are maybe not open access.

Pneumococcal Infections

Pediatrics In Review, 2004
Objectives: After completing this article, readers should be able to: 1. Discuss the common clinical presentations of pneumococcal infections. 2. Describe the resistance patterns of Streptococcus pneumoniae and the usual recommendations for therapy of pneumococcal infections. 3. Characterize the treatment of pneumococcal meningitis. 4.
openaire   +3 more sources

Pneumococcal Infection and Pneumococcal Vaccine

New England Journal of Medicine, 1977
The pneumococcus (Streptococcus pneumoniae) is a major cause of pneumonia, otitis media and meningitis throughout the world. Although the mortality resulting from pneumococcal infection has declined strikingly since the introduction of the sulfonamides, penicillin and other antibiotics, what limited epidemiologic evidence is available suggests that the
openaire   +3 more sources

Pneumococcal Infections

Pediatrics In Review, 2014
Overwhelmingly consistent evidence from observational studies has demonstrated that the pneumococcal conjugate vaccine has reduced the burden of pneumococcal disease but continues to affect the epidemiology of pneumococcal infections caused by nonvaccine serotypes and antibiotic-resistant pneumococci.
openaire   +2 more sources

Pathogenesis of Pneumococcal Infection

New England Journal of Medicine, 1995
The study of Streptococcus pneumoniae has led to many insights into the pathogenesis of bacterial infections. The importance of the polysaccharide capsule of the organism in determining its virulence was indicated by studies of the protective role of anticapsular antibodies.1–3 Of comparable importance was the observation that noncapsulated pneumococci
R Austrian, H R Masure, Elaine Tuomanen
openaire   +2 more sources

Pneumococcal Infections and Pneumococcal Vaccine: An Update

Infection Control, 1982
AbstractPneumococcal pneumonia continues to be an important disease in terms of prevalence, morbidity and mortality. With the discovery of penicillin and its wide clinical use, the overall mortality of pneumococcal pneumonia has been significantly reduced, but problems remain.
openaire   +3 more sources

Pharmacotherapy for pneumococcal infections: an update

Expert Opinion on Pharmacotherapy, 2012
The management of pneumococcal diseases still places a significant burden on medical and economic resources. The subjects at greatest risk of pneumococcal infections are children.The aim of this review is to analyse the best current therapeutic approach to pneumococcal resistance, taking into account the level of susceptibility of Streptococcus ...
Esposito, Susanna Maria Roberta   +1 more
openaire   +6 more sources

Pneumococcal infections

2010
Streptococcus pneumoniae is an encapsulated Gram-positive bacterium that lives almost exclusively in the human nasopharynx. Each pneumococcus expresses one of more than 90 immunologically distinguishable capsular polysaccharides that are the principal target of systemic human immunity and define its serotype ...
openaire   +1 more source

Treatment and Prevention of Pneumococcal Infection

Clinical Obstetrics & Gynecology, 2019
Streptococcus pneumoniae, a gram-positive diplococcus, is the most common cause of bacterial pneumonia. The diagnosis of pneumococcal pneumonia is usually confirmed by chest x-ray and gram stain. The most appropriate antibiotics for treatment pneumococcal infection are macrolides, beta-lactams, and quinolones.
Patrick Duff, Olivia Moumne
openaire   +3 more sources

Pneumococcal Infection and Immunization in Children

Critical Reviews in Microbiology, 1994
Pneumococcal infection persists as a major cause of pneumonia, bacteremia, and otitis media and is the important cause of meningitis in young children. Children less than 2 years of age show the highest incidence of pneumococcal diseases. Pneumococcal types 6A + 6B, 7F, 9V, 14, 18C, 19F + 19A, and 23F account for the large majority of disease isolates ...
Theresa R. Wang, Chi-Jen Lee
openaire   +2 more sources

Vaccination Against Pneumococcal Infection

Annals of Internal Medicine, 1986
Excerpt To the editor: In the article on cost effectiveness of vaccination against pneumococcal pneumonia, Sisk and Riegelman (1) estimate that, at most, 20% to 35% of the recommended target group ...
Mavis Siewert, Paul J. Drinka
openaire   +3 more sources

Home - About - Disclaimer - Privacy